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ARTICLE OPEN
Quality of spirometry and related diagnosis in primary care
with a focus on clinical use
S. J. van de Hei 1,2✉, B. M. J. Flokstra-de Blok2,3,4, H. J. Baretta1, N. E. Doornewaard1, T. van der Molen1,2, K. W. Patberg5,
E. C. M. Ruberg6, T. R. J. Schermer7, I. Steenbruggen6, J. W. K. van den Berg5 and J. W. H. Kocks 2,4
American and European societies’ (ATS/ERS) criteria for spirometry are often not met in primary care. Yet, it is unknown if quality is
sufficient for daily clinical use. We evaluated quality of spirometry in primary care based on clinical usefulness, meeting ATS/ERS
criteria and agreement on diagnosis between general practitioners (GPs) and pulmonologists. GPs included ten consecutive
spirometry tests and detailed history questionnaires of patients who underwent spirometry as part of usual care. GPs and two
pulmonologists assessed the spirometry tests and questionnaires on clinical usefulness and formulated a diagnosis. In total, 149
participants covering 15 GPs were included. Low agreements were found on diagnosis between GPs and pulmonologists 1 (κ=
0.39) and 2 (κ= 0.44). GPs and pulmonologists rated >88% of the tests as clinically useful, although 13% met ATS/ERS criteria. This
real-life study demonstrated that clinical usefulness of routine primary care spirometry tests was high, although agreement on
diagnosis was low.
npj Primary Care Respiratory Medicine           (2020) 30:22 ; https://doi.org/10.1038/s41533-020-0177-z
INTRODUCTION
Chronic airway diseases occur frequently, and it is estimated that
more than 300 million people suffer from asthma worldwide and
approximately 170 million people are affected by chronic
obstructive pulmonary disease (COPD)1. Spirometry is essential
for diagnosing airway obstruction and monitoring chronic
respiratory diseases and is recommended in national and
international guidelines2–5. Because most of the respiratory
patients are diagnosed and managed by their general practitioner,
spirometry is commonly used in primary care6. Performing
spirometry in primary care lowers the burden for patients by
preventing hospital visits, reduces the costs and provides quick
results for the general practitioner (GP). In 2007, almost all Dutch
General Practices had access to a spirometry facility, with two-
third of the practices making use of their own spirometer6.
Good-quality spirometry requires reliable equipment, coopera-
tion between a well-trained operator and a motivated patient, and
an experienced interpreter7. Education demonstrated a positive
effect on the quality of spirometry in primary care8,9. Furthermore,
conducting spirometry frequently seems important to maintain
the ability for accurate measurements9.
The quality of spirometry is traditionally assessed using the
measures of acceptability and repeatability as formulated by the
American Thoracic Society (ATS) and the European Respiratory
Society (ERS)7, and has been investigated in primary care9–12. A
Dutch study performed by Landman et al.12 demonstrated that
31.9% of spirometry tests in primary care practices and 60.3% of
spirometry tests in primary care laboratories (where specialised
lung function technicians conducted the tests) met the ATS/ERS
criteria. However, 83.7 and 96.5% of the tests conducted in
primary care practices and in primary care laboratories
respectively were estimated to be clinically useful based on the
opinion of experienced lung function technicians.
A different approach to quality of spirometry could be the
quality being sufficient for daily clinical use when combined with
structured clinical data. This approach of quality could be more
relevant for good clinical care than criteria to assess the quality of
the spirometry test itself. This study aimed to evaluate the quality
of spirometry in primary care practices by agreement on
respiratory diagnosis between general practitioners and pulmo-
nologist in a real-life setting. In addition, this study aimed to assess
the actual proportion of clinically useful spirometry tests in
primary care based on the opinion of pulmonologists.
RESULTS
General practices and participants
This study was conducted between June 2017 and September
2018 in 13 general practices covering 15 GPs and 16 practice
nurses. In total, 165 participants were screened for eligibility and
149 participants were included. Three practices only included nine
spirometry tests and two practices included 11 tests. A flowchart
of the study is shown in Fig. 1. The population consisted of 51.7%
males, with a mean age 56.8 years (SD 17.2) and the mean FEV1 %
predicted was 79.1% (SD 19.6%) (Table 1).
Agreement on diagnosis
The formulated diagnoses were reclassified into four categories:
asthma, COPD, no signs for respiratory disease and other (which
includes asthma/COPD overlap (ACO), restrictive disease, diag-
nosis unclear and other diagnosis). The overall observed agree-
ment on diagnosis between GPs and pulmonologist 1 was 55.7%
with κ 0.392 (95% CI 0.217−0.441). The overall agreement on
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diagnosis between GPs and pulmonologist 2 was the highest with an
observed agreement of 59.3% and a moderate agreement according
to Cohen’s kappa (κ 0.438, 95% CI 0.322−0.554). The overall
observed agreement on diagnosis between the pulmonologists was
55.3% with κ 0.382 (95% CI 0.268−0.496) (Table 2 and Fig. 2).
Additional post hoc analysis showed an overall observed
agreement on diagnosis between GPs and pulmonologists of
74.5% with a substantial agreement according to Cohen’s kappa
(κ 0.627, 95% CI 0.480−0.774), when only cases on which the two
pulmonologists agreed on the diagnosis of asthma, COPD or no
respiratory disease were analysed (n= 55). A good agreement
between GPs and pulmonologists was found for the diagnosis of
asthma (κ 0.825, 95% CI 0.662−0.988) (Fig. 2 and Supplementary
Table 1).
When looking at spirometry tests that met the ATS/ERS criteria
only (n= 20), a substantial to good agreement on COPD diagnosis
was found, whereas a moderate to substantial agreement was
found in spirometry tests that did not meet the ATS/ERS criteria (n
= 120) (Supplementary Table 2). Moreover, exclusion of respira-
tory disease tends to be more agreed on when the ATS/ERS
criteria are met. A smaller difference is found for agreement on
overall respiratory diagnosis; the agreement was moderate in tests
that met the ATS/ERS criteria compared to a fair agreement
(between GPs and pulmonologist 1 and between pulmonologists)
and a moderate agreement (between GPs and pulmonologist 2) in
tests that did not meet the ATS/ERS criteria.
ATS/ERS criteria
Only 20 spirometry tests (13.4%) met the full set of ATS/ERS
criteria (Table 3) (for the distribution of the individual practices,
see Supplementary Fig. 1). The main reason for not meeting the
criteria was poor compliance to the acceptability criteria, with the
criteria on the peak expiratory flow (PEF) (‘good start of expiration’
and ‘reached peak with maximal effort’) being the least adhered
to. The repeatability criteria were met in most of the spirometry
tests, when assessing all spirometry tests (regardless of obtaining
three acceptable curves). Of the 102 and 107 spirometry tests that
did not meet the ATS/ERS criteria as assessed by lung function
technicians 1 and 2 respectively, 22.5% and 20.6% of the
spirometry tests did not adhere to only one of the acceptability
criteria. When the criterion ‘exhalation ≥ 6 seconds’ was included
in the analysis, which was met in 73.2% (lung function technician
1) and 67.1% (lung function technician 2) of the tests, only 16
(10.7%) spirometry tests met the ATS/ERS criteria. The proportion
of spirometry tests that met the ATS/ERS criteria in the study
group was not significantly different from the proportion of tests
conducted prior to the study (11.1% vs. 13.4%, p value 0.804;
Supplementary Table 3).
Quality and clinical usefulness
Overall, more than 80% of spirometry tests were assessed as good













Assessment by two lung
function technicians (n= 149)
Exclusion because (GPs):
- Declined to participate (n= 2)
Exclusion because:
- Declined to participate (n= 13)
- <18 years (n= 1)
- Spirometry missing at general
practice (n= 1)
- Not able to read/write (n= 1)
Fig. 1 Flow of GPs and participants through the study. Flowchart.
Table 1. Characteristics of participating general practices and
participants.
General practices (n= 13)





Participation in accredited spirometry educational programme, n (%)
General practitioners (n= 15) 12 (80.0)
Practice nurses (n= 16) 14 (93.3)
Participants (n= 149)
Age (years), mean (SD) 56.8 (17.2)
Male sex, n (%) 77 (51.7)
BMI (kg/m2), mean (SD) 27.5 (5.2)
Smoking status, n (%)
Current smoker 30 (20.1)
Stopped <1 year ago 7 (4.7)
Stopped ≥1 year ago 60 (40.3)
Never smoker 52 (34.9)
Previous pulmonologist visit (n= 146), n (%)
No 95 (65.1)
Yes, <6 months ago 4 (2.7)
Yes, ≥6 months ago 47 (32.2)
Number of antibiotics/predniso(lo)ne courses in the previous year








MRC (n= 128), n (%)
0–2 116 (90.7)
>2 12 (9.3)





Total (n= 138) 1.0 (0.6–1.6)
Symptoms (n= 138) 1.6 (1.0–2.5)
Functional status (n= 139) 0.8 (0.3–1.5)
Mental (n= 139) 0.0 (0.0–0.5)
FEV1 (L)
a, mean (SD) 2.6 (1.0)
FEV1 % predicted
a, mean (SD) 79.1 (19.6)
FVC (L)a, mean (SD) 3.8 (1.1)
FEV1/FVC (%), mean (SD) 66.3 (12.4)
Reversibility testing performed, n (%) 90 (60.4)
BMI body mass index, MRC Medical Research Council dyspnoea scale, ACQ
Asthma Control Questionnaire, CCQ COPD Clinical Questionnaire, FEV1
forced expiratory volume in 1 s, FVC forced vital capacity.
aBased on largest pre-bronchodilator value.
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84.6%). Tests were rated as clinically useful in 92.5%, 87.5% and
99.3% of cases by the GPs, pulmonologist 1 and pulmonologist 2
respectively (Fig. 3, Supplementary Table 4).
Annual number of spirometry tests
No correlation was found between the annual number of
spirometry tests performed in the general practices and the
proportion of spirometry tests on which the GPs and pulmonol-
ogist 1 agreed on diagnosis (n= 12; Spearman’s correlation
coefficient −0.281, p value 0.377). However, a negative correlation
was found between the annual number of tests and the
proportion of tests on which the GPs and pulmonologist 2 agreed
on diagnosis (n= 12; Spearman’s correlation coefficient −0.635, P
value 0.027). No correlation was found between the annual
number of spirometry tests performed in the general practices
and the proportion of spirometry tests that met the ATS/ERS
criteria (n= 12; Spearman’s correlation coefficient 0.089, P value
0.784).
Treatment advice
GPs and pulmonologists 1 and 2 formulated the advice to
continue current treatment 58, 57 and 51 times respectively. In 23
and 24 cases the GPs and pulmonologists 1 and 2 agreed on this
advice. The pulmonologists recommended to stop current
Table 2. Agreement between GPs and pulmonologist 1 (a), GPs and
pulmonologist 2 (b) and pulmonologists (c) on the presence of
asthma, COPD, no respiratory disease or other diagnoses.
a
GP
Asthma COPD No disease Other Total
Pulm 1
Asthma 18 2 0 5 25
COPD 0 33 0 14 47
No disease 3 1 8 6 18
Other 20 2 9 19 50
Total 41 38 17 44 140
b
GP
Asthma COPD No disease Other Total
Pulm 2
Asthma 29 1 0 9 39
COPD 0 25 0 8 33
No disease 0 0 9 7 16
Other 12 12 8 20 52
Total 41 38 17 44 140
c
Pulm 1
Asthma COPD No disease Other Total
Pulm 2
Asthma 18 1 0 6 25
COPD 2 29 0 17 48
No disease 2 1 8 7 18
Other 17 2 8 23 50
Total 39 33 16 53 141













Overall diagnosis Asthma COPD
GPs vs. pulmonologist 1
GPs vs. pulmonologist 2
Pulmonologist 1 vs. pulmonologist 2
GPs vs. pulmonologists*
Fig. 2 Agreement on diagnosis. Agreement on overall diagnosis,
asthma and COPD between the GPs and pulmonologists (n= 140),
between the pulmonologists (n= 141) and between the GPs and
pulmonologists when only including cases on which the two
pulmonologists agreed on diagnosis (n= 55). *Includes all cases on
which the two pulmonologists agreed on diagnosis (n= 55).
Table 3. Spirometry tests that did and did not meet the ATS/ERS
acceptability and repeatability criteria (n= 149).
LFT 1 LFT 2
ATS/ERS criteria met (acceptability and
repeatability)
20 (13.4) 20 (13.4)
ATS/ERS criteria not met 102 (68.5) 107 (71.8)
ATS/ERS criteria not assessable 27 (18.1) 22 (14.8)
Acceptability (three acceptable curves)a 20 (13.4) 20 (13.4)
Good start of expiration (PEF reached quickly) 55 (36.9) 47 (31.5)
Reached peak with maximal effort 53 (35.6) 58 (38.9)
Smooth continuous exhalation 87 (58.4) 77 (51.7)
Good exhalation (no pinching) 94 (63.1) 88 (59.1)
No extra breaths being taken during
manoeuvre
142 (95.3) 140 (94.0)
Plateau (≥1 s < 0.025 L change in volume) 101 (67.8) 90 (60.4)
Repeatabilityb 136 (91.3) 136 (91.3)
Difference between two largest values of
FEV1 ≤ 0.150 L
146 (98.0) 146 (98.0)
Difference between two largest values of
FVC ≤ 0.150 L
136 (91.3) 136 (91.3)
Acceptability (≥2 acceptable curves) 49 (32.9) 49 (32.9)
All values are n (%).
ATS/ERS American Thoracic Society/European Respiratory Society, LFT lung
function technician.
aDuration is not used as a criterion for the three acceptable curves.
bRepeatability was assessed regardless of obtaining three acceptable
curves.
SJ van de Hei et al.
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medication more often than GPs (38 and 17 times vs. 2 times),
whereas the GPs recommended an increase in dose of current
medication more often (12 vs. 1 and 3 times). Both GPs and
pulmonologists 1 and 2 recommended smoking cessation, more
physical exercise and discussion of diet in more than 24 patients
(range 24–68). Review of medication adherence and inhaler
technique was frequently recommended by GP and pulmonolo-
gist 2 (26 and 32 times respectively), but only twice by
pulmonologist 1. Referral to a pulmonologist was only recom-
mended 6 times by the GPs and 34 and 45 times by
pulmonologists 1 and 2 respectively.
DISCUSSION
In this study, we evaluated the quality of spirometry by agreement
on respiratory diagnosis between GPs and pulmonologists in a
real-life setting. We found a low agreement on respiratory
diagnosis between GPs and pulmonologists and also between
the pulmonologists. Agreement on COPD was the highest,
followed by asthma. When only including cases on which
pulmonologists agreed on diagnosis, a much higher agreement
on diagnosis was found between GPs and pulmonologists. A
remarkably large difference was found in the amount of clinically
useful spirometry test as assessed by the pulmonologists and GPs
(87%) and spirometry tests that met the acceptability and
repeatability criteria as defined by ATS/ERS (13%).
Agreement on diagnosis based on spirometry has been
evaluated in two previously published studies13,14. However,
those studies were not comparable to the present study. One
study compared the assessment of standardised case descriptions
by GPs to a golden standard (consensus within an expert panel)
and offered all participating GPs a study-specific spirometry
training14. The second study only included patients with (a
suspicion of) COPD and provided spirometry training for the
participating GPs as well13. No studies were found that evaluated
agreement on diagnosis between GPs and pulmonologists with-
out providing study-specific spirometry training and using real
patients that were included consecutively.
Our finding of a large proportion of tests being clinically useful
is consistent with the study by Landman et al.12. In contrast to that
study, in which clinical usefulness of spirometry tests was based
on the opinion of lung function technicians, clinical usefulness in
the present study was based on the opinion of GPs and
pulmonologists. The current approach may be a more represen-
tative estimate of clinical usefulness, as physicians are the ones
who formulate a diagnosis and treatment advice in real-world
practice.
Adherence to the ATS/ERS criteria is found to be higher in other
studies conducted in a primary care setting (32−40%)11,12,15. This
difference could be partly explained by the requirement of only
two acceptable flow-volume curves in one of those studies12, as
their results are comparable to the 33% meeting the ATS/ERS
acceptability criteria in two curves found in the current study.
Furthermore, participation of the involved practices in a regional
working agreement with a hospital in the previous studies could
have influenced adherence to ATS/ERS criteria, as regular
spirometry training and support was part of this agreement12,15.
In addition, intensive study-specific spirometry training offered to
healthcare professionals administering the tests may explain the
difference in results15. Only one publication was found on
adherence to ATS/ERS criteria in secondary care, showing that
41% of the assessed spirometry tests met the ATS/ERS criteria16.
‘Duration of exhalation of a minimum of six seconds’ and
‘reaching a volume/time plateau for longer than one second’ have
been identified as the ATS/ERS criteria the least adhered to in
spirometry testing in primary care11,12. This could result in
underestimation of FVC and thus, an overestimation of the FEV1/
FVC ratio. As a consequence, airway obstruction may be under-
estimated. In contrast to those previous studies, we found the
criteria ‘good start of expiration’ and ‘reached peak with maximal
effort’, to be the criteria the least adhered to. A suboptimal PEF
could lead to an underestimation and even an overestimation of
FEV1, which may result in an under- or overestimation of airway
obstruction. One of the reasons for poor scores on the PEF-related
criteria might be the fact that the software used by general
practices did not recognise a poor PEF in most of the cases.
Although nearly all participating practice nurses followed a
spirometry course, they might rely too much on the support of
the software. In addition, the problem of underestimation of FVC is
highlighted in current education programmes, which might have
resulted in improvement of the related criteria. To improve
diagnostic accuracy, future spirometry training should focus more
on the importance of a good start and peak. Also, the PEF should
receive more attention in the development of spirometry software
programmes.
Besides the poor compliance to PEF-related criteria, one out of
six spirometry tests was not assessable at all. This was mostly due
to wrong spirometry settings (e.g. start of spirometry not visible in
curve), an improperly maintained flow sensor (e.g. no plateau
reached after 15 s of exhalation) or wrong printing settings (e.g.
composite curves). We have included these spirometry tests in the
analyses, as these are the spirometry tests that are used by the GP
to provide clinical advice and therewith, reflect daily practice.
A limitation of this study was that the assessment of diagnosis
by GPs could have been influenced by the fact that GPs possibly
know study participants from previous consultations. For example,
it is known that airway obstruction is not always found by
spirometry testing in mild to moderate asthma patients3. In these
patients, assessment of diagnosis was based on the completed
questionnaires and an inconclusive spirometry. GPs could have
formulated the diagnosis asthma if they knew the study
participant from previous consultations, whereas the pulmonolo-
gist assessed anonymised data and would not formulate the
diagnosis asthma. We estimate this influence to be small, as both
GPs and pulmonologists had access to the completed ques-
tionnaires, which included respiratory history filled in by the
patient and by the practice nurse. Furthermore, only consecutive












Fig. 3 Clinical usefulness, quality of spirometry and ATS/ERS
criteria. Clinical usefulness and quality of the spirometry tests (n=
149) as assessed by the GPs and pulmonologists and ATS/ERS criteria
as assessed by the lung function technicians. GP general practi-
tioner, Pulm pulmonologist, ATS/ERS American Thoracic Society/
European Respiratory Society. *One assessment by the GPs was
missing.
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this study. In the Dutch primary care setting, often one out of two
to four GPs in a practice is trained and reviews all spirometry tests,
including those from patients of GP colleagues.
In total, one out of three spirometry tests combined with the
structured clinical data was assigned the diagnosis ‘unclear’ by the
pulmonologists. No additional investigations were performed in
those patients to find a diagnosis, as this was not the aim of the
study. However, most of the spirometry tests were assessed as
clinically useful (74.5% and 100% of the tests that had been
assigned the diagnosis ‘unclear’ by pulmonologists 1 and 2
respectively). Furthermore, the diagnosis ‘unclear’ was not
expected to be assigned less often when the pulmonologists
would have performed live assessments, as in previous research
good concordance was found between live assessment and paper
assessment (κ 0.82)17,18. This reflects the difficulties in formulating
a diagnosis based on the diagnostic facilities available in primary
care respiratory medicine, which would warrant referral in one
third of patients for further assessment19,20.
In this study, the respiratory diagnosis as formulated by the
pulmonologist was supposed to be the gold standard. To ensure
the gold standard was represented thoroughly, we have chosen to
include two pulmonologists, as we did for the lung function
technicians. The agreement on ATS/ERS criteria between the lung
function technicians was good (κ 0.67 before consensus meetings,
κ 0.81 after consensus meetings). In contrast, the agreement on
diagnosis between the pulmonologists was only fair according to
kappa (κ 0.38). In COPD the agreement was highest, but not as
high as could be expected based on the fact that COPD is a
diagnosis strictly defined by spirometry findings. Variation in
diagnosis in respiratory medicine has been found before. In
asthma for example, the diagnosis is the result of a complex
assessment because it is less dependent on spirometry, resulting
in higher variation between physicians and relevant misdiagno-
sis19. We performed a post hoc analysis using only cases on which
the two pulmonologists agreed on the diagnosis, showing a
substantial agreement on diagnosis between GPs and pulmonol-
ogists according to Cohen’s kappa. As numbers are small (n= 55),
these results should be confirmed in larger studies. For future
evaluation of diagnostic accuracy, the gold standard might need
to be extended with an expert panel.
The advantages of performing spirometry in primary care are
large, but sufficient quality should be assured. This real-life study
demonstrated that agreement on respiratory diagnosis between
GPs and pulmonologists is relatively low, as is the agreement
between pulmonologists, based on spirometry, patient history and
symptoms. When assessing the group of patients in which the two
pulmonologists both agreed on the diagnosis, agreement
between pulmonologists and GPs was much higher. Only a few
spirometry tests met ATS/ERS criteria, but clinical usefulness was
very high as rated by both GPs and pulmonologists. This suggests
that meeting the ATS/ERS criteria may not be required for
providing a diagnosis, when physicians are offered spirometry
results and questionnaires on patient history and symptoms.
However, it is unclear if quality of spirometry based on the
formulated diagnosis is higher when the ATS/ERS criteria are met.
Therefore, further research should focus on evaluating the
influence of meeting ATS/ERS criteria on clinical decision making
in a real-life setting.
METHODS
Study design and participants
This prospective observational study was conducted in general practices in
the area of Zwolle, the Netherlands. All spirometry-performing general
practices interested in participating were eligible for inclusion. Practices in
the area of Zwolle were invited to participate by phone or e-mail. Effort
was put into including regular practices in the study, also those that do not
regularly take part in respiratory medical research. All participants aged 18
years and over, who underwent spirometry as part of usual care indicated
by their GP, were eligible for inclusion in this study and were asked to
participate. All participating GPs were asked to include ten spirometry tests
from ten consecutive patients performed in their general practice
irrespective of the eventual diagnosis, to ensure objective inclusion of
spirometry tests. In addition, practices were asked to provide three
spirometry tests performed one, two and three months before the start of
study. All general practices performed spirometry tests according to the
ATS/ERS guidelines7. Administration of bronchodilators to perform
reversibility testing was done only when indicated by the GP. The medical
ethics committee of the University Medical Center Groningen (UMCG)
deemed that formal medical ethical approval was not required, as this
study did not fall under the Dutch Medical Research Involving Human
Subjects Act. This study is reported in accordance with the ‘Strengthening
the reporting of observational studies in epidemiology’ (STROBE)
Statement21.
Study procedures
Written informed consent was obtained from participants before starting
any study-specific procedures. Participants were able to withdraw from the
study during their participation, without giving a reason. Participants were
asked to complete a medical history questionnaire based on the Dutch
asthma and COPD guidelines (Supplementary Table 5)4,5, assessing gender,
age, BMI, respiratory medication use, smoking status, comorbidities, age of
onset of respiratory symptoms, family respiratory history, profession,
bronchial hyperresponsiveness and whether or not a patient visits a
pulmonologist on a regular basis. Furthermore, the following question-
naires were completed: the Medical Research Council (MRC) dyspnoea
scale with higher scores indicating more impact of breathlessness on daily
activities22, the Asthma Control Questionnaire (ACQ) measuring asthma
control (five items) with higher scores indicating worse asthma control23,
and the Clinical COPD Questionnaire (CCQ) assessing health status in COPD
patients (ten items) with higher scores indicating worse health status24.
After completion of the questionnaires, spirometry was performed. The
practice nurse was asked to select three pre-bronchodilator curves and,
when performed, three post-bronchodilator curves. Participating general
practices were asked to fill in questions about the type of spirometer,
frequency of calibration of the spirometer, the annual number of
spirometry tests performed, number of operators in the practice and the
date of last participation in a spirometry education programme.
Assessment of spirometry tests
GPs formulated a diagnosis and treatment advice for all included patients
of their general practice, based on the completed questionnaires and
spirometry test results printed on paper including post-bronchodilator
curves when performed. In addition, GPs assessed the spirometry tests
results on quality (good, moderate or poor) and clinical usefulness (useful
or not useful). In this case, clinical usefulness means that the quality of
spirometry is considered sufficient to make clinical decisions. An example
of the assessment form is provided in Supplementary Fig. 2.
Subsequently, the spirometry test results on paper supplied with the
completed questionnaires on paper were sent to two pulmonologists from
the Isala Hospital in Zwolle. All spirometry test results had the same lay-out
and patient identifiers were removed from the spirometry test results
before sending. The pulmonologists evaluated the spirometry test results
on the same criteria as the GPs did. The pulmonologists were blinded for
the assessment of the GP and for each other’s assessments.
Two lung function technicians from the Pulmonary Laboratory in the
Isala Hospital assessed the spirometry test results (including the spirometry
tests performed prior to the study) on acceptability and repeatability as
defined by the ATS/ERS criteria, which are specified in Box 1 7,25. According
to the ATS/ERS criteria, a subject should try to exhale for at least 6 s.
However, some healthy adults are able to empty their lungs within 6 s. The
lung function technicians were not able to assess if subjects tried to exhale
for at least 6 s, because they did not conduct the test themselves.
Therefore, the criterion ‘duration exhalation ≥ 6 s’ has not been included in
our main analysis, meaning that reaching a plateau (≥1 s < 0.025 L change
in volume) within 6 s was sufficient to meet the end of test criteria. A
sensitivity analysis in which the duration criterion is included has been
performed. A spirometry test was considered ‘not assessable’ when the
lung function technicians were not able to assess one or more ATS/ERS
criteria (e.g. because of wrong software settings). In addition, the lung
function technicians assessed the number of acceptable curves according
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to the ATS/ER criteria. After completing data collection, consensus
meetings were held to discuss disagreement in assessment between the
two lung function technicians. All tests with disagreement on acceptability
or repeatability (i.e. one lung function technician assessed the spirometry
as acceptable or repeatable, while the other lung function technician did
not) were discussed. Furthermore, tests that were considered as not
assessable by one lung function technician were discussed when
acceptability or repeatability could still be met by discussing the
assessments. In all cases, discussion was sufficient to resolve the
disagreement between the technicians. Finally, tests with disagreement
on the number of acceptable curves according to the lung function
technician’s opinion were discussed.
Sample size
The sample size was calculated using the method of Cohen’s Kappa as
described by Cantor26. The calculation was made by estimating kappa with
a 95% confidence interval (95%CI) of ±0.15. No assumptions were made
concerning the size of kappa; therefore, the minimal possible kappa was
used. In this method the variable Q, associated with kappa, was used to
calculate the sample size. Based on a study by Schneider et al.15, the
diagnosis asthma is expected to be made in 56% of cases by the GP and in
41% of cases by the pulmonologist. The minimum kappa was associated
with Q= 0.852 26. As a result, 146 participants were needed.
Statistical analysis
Study data were collected and managed using REDCap (Research
Electronic Data Capture)27. The statistical analysis was performed using
the statistics software package IBM SPSS Statistics for Windows, version
25.0 (IBM Corp., Armonk, NY). Participant and general practice character-
istics were summarised using descriptive statistics and frequency
distributions. Baseline characteristics are shown as mean ± standard
deviation or, in case of non-normally distributed data, median and
interquartile range (IQR). The primary outcome of this study was
agreement between the GP and pulmonologists on the formulated
diagnosis. Agreement on diagnosis is not expected in spirometry tests of
poor quality or tests that are clinically useless. Therefore, spirometry tests
that were assessed as being clinically useless by both pulmonologists were
excluded from the analysis. Also, tests that were assessed as being of poor
quality by both pulmonologists or as moderate quality by one
pulmonologist and poor quality by the other pulmonologist were excluded
from the analysis. Agreement on diagnosis is expressed as observed
agreement and Cohen’s kappa (κ). Observed agreement is defined as the
number of tests on which the raters agree with each other divided by the
total number of tests (a+ d/N). Agreement with Cohen’s kappa is
interpreted as described by Landis and Koch28: κ > 0.81 is considered a
good agreement, κ > 0.61 a substantial agreement, κ > 0.41 a moderate
agreement and κ > 0.21 a fair agreement. In addition, a post hoc analysis
was performed on agreement on diagnosis between the GPs and
pulmonologists, only including cases on which the two pulmonologists
agreed on diagnosis of asthma, COPD or no respiratory disease. This
agreement is expressed as observed agreement and Cohen’s kappa.
Prespecified secondary outcomes included (1) interrater agreement on
diagnosis between the two pulmonologists expressed as observed
agreement and Cohen’s kappa, (2) proportion spirometry tests that met
and did not meet the ATS/ERS criteria, (3) proportion of clinically useful
spirometry tests and proportion of spirometry tests of good quality based
on the opinion of GPs and pulmonologists, (4) agreement on diagnosis in
spirometry tests that did and did not meet ATS/ERS criteria expressed as
Cohen’s kappa, (5) the correlation between the proportion of spirometry
tests on which the GP and pulmonologist agreed on diagnosis and the
yearly number of spirometry tests performed by the GP (Spearman’s
correlation coefficient), (6) the correlation between the proportion of
spirometry tests that met the ATS/ERS criteria and the yearly number of
spirometry tests performed by the GP (Spearman’s correlation coefficient),
(7) whether the Hawthorne effect (change of behaviour in response to the
awareness of participation in a trial) was present by comparing
the proportion of spirometry tests that met the ATS/ERS criteria before
the start of the study and during the study and (8) frequencies of the
formulated treatment advices.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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